Scarica l'app Stockscreener
153.49
2.49%
3.73
Pre-mercato:
152.41
-1.08
-0.70%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina stock target lifted amid strong margins and consumables drive growth - Investing.com
Illumina revenue dips 2% to USD 1.1 billion for Q3 2024 - Medical Buyer
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Van ECK Associates Corp - MarketBeat
Bioinformatics Market Forecasted to Reach $29.1 Billion by 2031 | Illumina Inc., Thermo Fischer Scientific, Qiagen NV - openPR
Earnings call: Illumina reports mixed Q3 results, plans for future growth - Investing.com
Vanguard Group Inc's Strategic Acquisition of Illumina Inc Shares - GuruFocus.com
Illumina Introduces the MiSeq i100 Series - MPO-mag
Illumina Reports Q3 2024 Financial Results Amid Strategic Expansion - TipRanks
Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - TradingView
Illumina: Q3 Earnings Snapshot - San Antonio Express-News
Illumina (NASDAQ:ILMN) Updates FY 2024 Earnings Guidance - MarketBeat
Illumina stock falls 6% amid lowered 2024 revenue guidance - MSN
Illumina stock falls 6% amid lowered 2024 revenue guidance (NASDAQ:ILMN) - Seeking Alpha
Illumina shares fall 5% as Q4 revenue guidance disappoints By Investing.com - Investing.com Nigeria
Illumina shares fall 5% as Q4 revenue guidance disappoints - Investing.com
Illumina, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 - PR Newswire
Illumina (NASDAQ:ILMN) Hits New 12-Month HighStill a Buy? - MarketBeat
Illumina Inc (ILMN) Trading 3.49% Higher on Nov 4 - GuruFocus.com
Enabling single-cell sequencing for every laboratory - Illumina
Illumina stock soars to 52-week high, reaches $152.12 - Investing.com
Illumina to present updates on several key innovations in whole-genome sequencing at ASHG meeting - The Financial Express
Illumina Q3 24 Earnings Conference Call At 4:30 PM ET - Nasdaq
Epigenetics Market Types and Applications, Drivers, Ongoing - openPR
At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies - Genetic Engineering & Biotechnology News
Argonautica Private Wealth Management Inc. Takes $569,000 Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by New York State Teachers Retirement System - MarketBeat
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
NXP, Illumina, Vertex set to report earnings Monday By Investing.com - Investing.com Australia
NXP, Illumina, Vertex set to report earnings Monday - Investing.com
Stephens Investment Management Group LLC Has $28.01 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting - PR Newswire
Illumina Leads the Way With Its Steps Against Cancer Campaign - ReportAlert.info
Hudson Valley Investment Advisors Inc. ADV Boosts Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 Earnings - MSN
Comprehensive Study of Microfluidic Market 2024-2031 Trends, - openPR
Celebrating Diwali in India for the first time in 20 years - Illumina
Illumina leads the way with its Steps Against Cancer campaign - Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Deltec Asset Management LLC - MarketBeat
(ILMN) Trading Report - Stock Traders Daily
Strategic Buy Lights Up This Biotech Stock: Time to Invest? - MSN
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock? - MSN
Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
The Emerging Population Genomics Revolution - ReportAlert.info
The emerging population genomics revolution - Illumina
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina (ILMN) Set to Announce Quarterly Earnings on Monday - MarketBeat
DNA Microarray Global Market Rising Trends, Industry Size, - openPR
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Illumina's SWOT analysis: stock outlook amid sequencing market shifts - Investing.com India
Illumina's SWOT analysis: stock outlook amid sequencing market shifts By Investing.com - Investing.com South Africa
DNA Microarray Market Analysis: Segments, Drivers, - openPR
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers - The Manila Times
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zurich lab imagines new possibilities in microbial research and diagnostics - Illumina
Cancer Biomarkers Industry Analysis and Market Opportunities, Forecast to 2029A Forecasted $42 Billion Landscape, Dominated by Roche, Thermo Fisher Scientific, QIAGEN, Illumina, and Bio-Rad Labs - GlobeNewswire
Illumina launches next-gen benchtop sequencers with sustainable and comprehensive approach - BSA bureau
SG Americas Securities LLC Sells 22,245 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Raymond James & Associates Raises Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
0.03%
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):